Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Mass Screening × Classical hematology × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 6 Gynecologic 3 Breast 3 Other hematologic neoplasm 2 Head & Neck 2 Thoracic 1 Plasma cell 1 Other solid neoplasm 1 Myeloid 1 Lymphoid 1 Classical hematology 1

Conditions

Venous Thromboembolism 1 Neoplasms 1

Interventions

Surveys and Questionnaires 7 Rivaroxaban 7 Heparin, Low-Molecular-Weight 4 fludarabine 3 apixaban 3 pegfilgrastim 2 epoetin beta 2 Therapeutics 2 Polymerase Chain Reaction 2 Piperacillin, Tazobactam Drug Combination 2 Observation 2 Melphalan 2 Epoetin Alfa 2 Data Collection 2 Dabigatran 2 ziprasidone 1 ribociclib 1 palbociclib 1 oprelvekin 1 iron isomaltoside 1000 1 fludarabine phosphate 1 edoxaban 1 calcium heparin 1 avatrombopag 1 acarboxyprothrombin 1 abemaciclib 1 Zolpidem 1 Warfarin 1 Vecuronium Bromide 1 Vancomycin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01088334 2010-03-29

Trousseau

Slotervaart Hospital

Classical hematology

Neoplasms, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡